These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9625172)

  • 1. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.
    Schorge JO; Muto MG; Welch WR; Bandera CA; Rubin SC; Bell DA; Berkowitz RS; Mok SC
    J Natl Cancer Inst; 1998 Jun; 90(11):841-5. PubMed ID: 9625172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.
    Huang LW; Garrett AP; Schorge JO; Muto MG; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Am J Clin Pathol; 2000 Jul; 114(1):93-9. PubMed ID: 10884804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary peritoneal carcinoma can have multifocal origins: implications for prophylactic oophorectomy.
    Eisen A; Weber BL
    J Natl Cancer Inst; 1998 Jun; 90(11):797-9. PubMed ID: 9625162
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.
    Bandera CA; Muto MG; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jul; 16(26):3455-9. PubMed ID: 9692553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis.
    Schorge JO; Muto MG; Lee SJ; Huang LW; Welch WR; Bell DA; Keung EZ; Berkowitz RS; Mok SC
    Cancer Res; 2000 Mar; 60(5):1361-4. PubMed ID: 10728699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.
    Schorge JO; Miller YB; Qi LJ; Muto MG; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Mar; 76(3):369-72. PubMed ID: 10684712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
    Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is papillary serous carcinoma of the peritoneum (PSCP) a multifocal disease?
    Imura J; Fujimori T
    J Gastroenterol; 2000; 35(7):570-2. PubMed ID: 10905369
    [No Abstract]   [Full Text] [Related]  

  • 9. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.
    Muto MG; Welch WR; Mok SC; Bandera CA; Fishbaugh PM; Tsao SW; Lau CC; Goodman HM; Knapp RC; Berkowitz RS
    Cancer Res; 1995 Feb; 55(3):490-2. PubMed ID: 7834614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
    Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
    Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
    Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors.
    Nishimura- M; Wakabayashi M; Hashimoto T; Shibata J; Ueyama H; Ebina M; Fujiyama Y; Bamba T
    J Gastroenterol; 2000; 35(7):540-7. PubMed ID: 10905363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum.
    Bandera CA; Muto MG; Schorge JO; Berkowitz RS; Rubin SC; Mok SC
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):596-600. PubMed ID: 9764635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
    Buller RE; Sood AK; Lallas T; Buekers T; Skilling JS
    J Natl Cancer Inst; 1999 Feb; 91(4):339-46. PubMed ID: 10050867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
    Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
    Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
    Hornreich G; Beller U; Lavie O; Renbaum P; Cohen Y; Levy-Lahad E
    Gynecol Oncol; 1999 Nov; 75(2):300-4. PubMed ID: 10525392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 germline mutations in women with uterine serous papillary carcinoma.
    Lavie O; Hornreich G; Ben Arie A; Renbaum P; Levy-Lahad E; Beller U
    Obstet Gynecol; 2000 Jul; 96(1):28-32. PubMed ID: 10862837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
    Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
    World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.